NO994303D0 - Crystalline hydrated sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidenomethyl) -1H-indole-2-carboxylic acid - Google Patents

Crystalline hydrated sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidenomethyl) -1H-indole-2-carboxylic acid

Info

Publication number: NO994303D0
Authority: NO; Norway
Prior art keywords: ylidenomethyl; phenylpyrrolidin; indole; dichloro; oxo
Prior art date: 1997-03-05

Application number

NO994303A

Other languages

Norwegian (no)

Other versions

NO994303L (en

Inventor

Zadeo Cimarosti

Paolo Maragni

Original Assignee

Glaxo Wellcome Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-05

Filing date

1999-09-03

Publication date

1999-09-03

1999-09-03 Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa

1999-09-03 Publication of NO994303D0 publication Critical patent/NO994303D0/en

1999-11-03 Publication of NO994303L publication Critical patent/NO994303L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrrole Compounds (AREA)

NO994303A 1997-03-05 1999-09-03 Crystalline hydrated sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidenomethyl) -1H-indole-2-carboxylic acid NO994303L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9704498.6A GB9704498D0 (en)	1997-03-05	1997-03-05	Chemical compound
PCT/EP1998/001146 WO1998039327A1 (en)	1997-03-05	1998-03-03	Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid

Publications (2)

Publication Number	Publication Date
NO994303D0 true NO994303D0 (en)	1999-09-03
NO994303L NO994303L (en)	1999-11-03

Family

ID=10808697

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO994303A NO994303L (en)	1997-03-05	1999-09-03	Crystalline hydrated sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidenomethyl) -1H-indole-2-carboxylic acid

Country Status (29)

Country	Link
EP (1)	EP0966463A1 (en)
JP (1)	JP2001513796A (en)
KR (1)	KR20000075907A (en)
CN (1)	CN1249750A (en)
AP (1)	AP9901637A0 (en)
AR (1)	AR011178A1 (en)
AU (1)	AU6825198A (en)
BG (1)	BG103779A (en)
BR (1)	BR9808305A (en)
CA (1)	CA2282851A1 (en)
CO (1)	CO4940415A1 (en)
EA (1)	EA199900710A1 (en)
EE (1)	EE9900387A (en)
GB (1)	GB9704498D0 (en)
HR (1)	HRP980114A2 (en)
HU (1)	HUP0002109A2 (en)
ID (1)	ID24207A (en)
IL (1)	IL131489A0 (en)
IS (1)	IS5166A (en)
NO (1)	NO994303L (en)
NZ (1)	NZ337315A (en)
OA (1)	OA11154A (en)
PE (1)	PE51399A1 (en)
PL (1)	PL335652A1 (en)
SK (1)	SK119699A3 (en)
TR (1)	TR199902117T2 (en)
WO (1)	WO1998039327A1 (en)
YU (1)	YU43499A (en)
ZA (1)	ZA981791B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9704499D0 (en) *	1997-03-05	1997-04-23	Glaxo Wellcome Spa	Method of manufacture
GB9825988D0 (en)	1998-11-27	1999-01-20	Pfizer Ltd	Indole derivatives
GB9915231D0 (en)	1999-06-29	1999-09-01	Pfizer Ltd	Pharmaceutical complex
US9737531B2 (en)	2012-07-12	2017-08-22	Glytech, Llc	Composition and method for treatment of depression and psychosis in humans
AU2018284335A1 (en)	2017-06-12	2020-01-30	Glytech Llc.	Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9321221D0 (en) *	1993-10-14	1993-12-01	Glaxo Spa	Heterocyclic compounds

1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
1998
- 1998-03-03 CO CO98011404A patent/CO4940415A1/en unknown
- 1998-03-03 AR ARP980100948A patent/AR011178A1/en unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/en active Pending
- 1998-03-03 ID IDW990976A patent/ID24207A/en unknown
- 1998-03-03 JP JP53813598A patent/JP2001513796A/en active Pending
- 1998-03-03 YU YU43499A patent/YU43499A/en unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/en unknown
- 1998-03-03 PL PL98335652A patent/PL335652A1/en unknown
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/en not_active Application Discontinuation
- 1998-03-03 EA EA199900710A patent/EA199900710A1/en unknown
- 1998-03-03 EE EEP199900387A patent/EE9900387A/en unknown
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Ceased
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 IL IL13148998A patent/IL131489A0/en unknown
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/en unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/en unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/en not_active Withdrawn
- 1998-03-03 PE PE1998000149A patent/PE51399A1/en not_active Application Discontinuation
- 1998-03-03 SK SK1196-99A patent/SK119699A3/en unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/en not_active Application Discontinuation
1999
- 1999-08-27 IS IS5166A patent/IS5166A/en unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/en unknown
- 1999-09-03 NO NO994303A patent/NO994303L/en not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/en unknown

Also Published As

Publication number	Publication date
AU6825198A (en)	1998-09-22
ID24207A (en)	2000-07-13
BG103779A (en)	2000-06-30
AR011178A1 (en)	2000-08-02
SK119699A3 (en)	2000-05-16
TR199902117T2 (en)	2000-03-21
KR20000075907A (en)	2000-12-26
JP2001513796A (en)	2001-09-04
PE51399A1 (en)	1999-06-07
IL131489A0 (en)	2001-01-28
CO4940415A1 (en)	2000-07-24
CA2282851A1 (en)	1998-09-11
AP9901637A0 (en)	1999-09-30
EA199900710A1 (en)	2000-04-24
EE9900387A (en)	2000-04-17
CN1249750A (en)	2000-04-05
NZ337315A (en)	2001-02-23
HUP0002109A2 (en)	2001-04-28
BR9808305A (en)	2000-05-16
GB9704498D0 (en)	1997-04-23
EP0966463A1 (en)	1999-12-29
HRP980114A2 (en)	1998-12-31
IS5166A (en)	1999-08-27
PL335652A1 (en)	2000-05-08
YU43499A (en)	2000-12-28
OA11154A (en)	2003-04-16
WO1998039327A1 (en)	1998-09-11
NO994303L (en)	1999-11-03
ZA981791B (en)	1999-09-03

Publication	Publication Date	Title
DE69811892D1 (en)	2003-04-10	CRYSTALLINE FORM OF OMEPRAZOLE SODIUM SALT
DE59912742D1 (en)	2005-12-08	SUBSTITUTED PYRAZONE DERIVATIVES
NO20013665L (en)	2001-07-26	Potassium salt of (S) -omeprazole
EE04772B1 (en)	2007-02-15	3-Aryl-2-hydroxypropanoic acid derivative (I)
PT1077957E (en)	2004-10-29	OXY-IMINOALCANOIC ACID DERIVATIVES
DK1001934T3 (en)	2002-12-30	Indole compounds as COX-2 inhibitors
NO20011083L (en)	2001-05-03	Crystalline forms of EtOC2 - CH2 - (R) Cgl-Aze-Pab-OH
FI950568A7 (en)	1995-08-11	5-Heteroaryl indole derivatives
NO994303D0 (en)	1999-09-03	Crystalline hydrated sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidenomethyl) -1H-indole-2-carboxylic acid
NO996448D0 (en)	1999-12-23	Underwater well intervention system
DE69824279D1 (en)	2004-07-08	Stabilized sodium carbonate peroxyhydrate
FI970314L (en)	1998-07-25	Stabilized sodium carbonate peroxyhydrate
HK1022899A (en)	2000-08-25	Crystalline hydrated sodium salt of (e)-4, 6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
FI960424A0 (en)	1996-01-30	Substituted indole derivatives
DK1068198T3 (en)	2003-09-22	5-Heteroaryl substituted indoles
DE50004107D1 (en)	2003-11-20	SODIUM VALPROAT GRANULES WITH REDUCED HYGROSCOPICITY
DZ3463A1 (en)	2001-05-03	CRYSTALS OF SODIUM HYDROGEN TYPE 1 EXCHANGER INHIBITORS
NO20010972L (en)	2001-05-09	System for transmitting data packets
DE50013257D1 (en)	2006-09-14	Highly alkaline crystalline sodium silicate
ATE414059T1 (en)	2008-11-15	CRYSTALLINE FORM OF THE SODIUM SALT OF 5-CHLORINE-2-METHOXY-N-(2-(4-METHOXY-3-METHYLAMINOTHIOCARBONYLAMINOSULFONYLPHENYL)ETHY )BNZAMIDE
SI0991641T1 (en)	2003-08-31	Crystalline form of omeprazole sodium salt
ID21508A (en)	1999-06-17	PROCESS FOR MANUFACTURE OF INDOL 1- (AMINO-ALKIL) COMPOUNDS.
NO961495D0 (en)	1996-04-15	Fishing line production system

Legal Events

Date	Code	Title	Description
2002-11-18	FC2A	Withdrawal, rejection or dismissal of laid open patent application